1. Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice guidelines. Circulation. 2019;139(14):e698–800.
2. Taggart NW, Mohammed YQ. Patent ductus arteriosus and aortopulmonary window. In: Allen HD, Shaddy RE, Penny DJ, Feltes TF, Cetta F, editors. Moss and Adams’ heart disease in infants, children, and adolescents: including the fetus and young adults, vol. 1. 9th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2016.
3. Wilson WM, Shah A, Osten MD, Benson LN, Abraha N, Breitner D, et al. Clinical outcomes after percutaneous patent ductus arteriosus closure in adults. Can J Cardiol. 2020;36(6):837–43.
4. Sommer RJ, Hijazi ZM, Rhodes JF Jr. Pathophysiology of congenital heart disease in the adult: part I: shunt lesions. Circulation. 2008;117(8):1090–9.
5. Sudhakar P, Jose J, George OK. Contemporary outcomes of percutaneous closure of patent ductus arteriosus in adolescents and adults. Indian Heart J. 2018;70(2):308–15.